TY - JOUR
T1 - Use of ambulatory glucose monitoring and analysis of ambulatory glucose profile in clinical practice for diabetes management; a position statement of the Arab Society of Paediatric Endocrinology and diabetes
AU - Deeb, Asma
AU - Muammar, Tawfik
AU - Alsaffar, Hussain
AU - Sedaghat, Sara
AU - Al Hassani, Noura
AU - Odeh, Rasha
AU - Alkhayyat, Haya
AU - Al Sinani, Aisha
AU - Attia, Najya
AU - Adhami, Sarah
AU - Elbarbary, Nancy
N1 - Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2021/3
Y1 - 2021/3
N2 - Background and aim: Diabetes mellitus imposes a significant burden around the world generally and in the Middle East and North Africa specifically. Glucose monitoring is a cornerstone of diabetes management. Methods: Glycated haemoglobin has always been the main metric for assessing glycaemic control, but its use is linked with multiple pitfalls. As an alternative, continuous glucose monitoring is becoming a standard of care in many countries. Intermittent scanning glucose monitoring (isCGM) has acquired a worldwide popularity and has been proven to improve glycaemic control, hypoglycaemia detection and prevention, and quality of life. Results: The most recent International Society of Paediatric and Adolescent Diabetes practice. guidelines recommended its use in young people with diabetes observing Ramadan to ensure safe fasting. At a meeting in Abu Dhabi in November 2019, the Arab Society for Paediatric. Endocrinology and Diabetes brought together a number of regional diabetes experts, patient. representatives and international expert advisors to review the evidence for isCGM and propose. guidelines for its use in the Middle East and North Africa region. Conclusion: In this paper, the authors strongly recommend the use of isCGM for patients in MENA and present general recommendations and compressive specific guidance for physicians and patients, which they believe will also have wider resonance.
AB - Background and aim: Diabetes mellitus imposes a significant burden around the world generally and in the Middle East and North Africa specifically. Glucose monitoring is a cornerstone of diabetes management. Methods: Glycated haemoglobin has always been the main metric for assessing glycaemic control, but its use is linked with multiple pitfalls. As an alternative, continuous glucose monitoring is becoming a standard of care in many countries. Intermittent scanning glucose monitoring (isCGM) has acquired a worldwide popularity and has been proven to improve glycaemic control, hypoglycaemia detection and prevention, and quality of life. Results: The most recent International Society of Paediatric and Adolescent Diabetes practice. guidelines recommended its use in young people with diabetes observing Ramadan to ensure safe fasting. At a meeting in Abu Dhabi in November 2019, the Arab Society for Paediatric. Endocrinology and Diabetes brought together a number of regional diabetes experts, patient. representatives and international expert advisors to review the evidence for isCGM and propose. guidelines for its use in the Middle East and North Africa region. Conclusion: In this paper, the authors strongly recommend the use of isCGM for patients in MENA and present general recommendations and compressive specific guidance for physicians and patients, which they believe will also have wider resonance.
KW - Intermittent scanning continual glucose monitoring (isCGM)
KW - Middle East and North Africa (MENA)
KW - Ramadan
KW - ambulatory glucose profile (AGP) time in range
KW - haemoglobinopathies
UR - http://www.scopus.com/inward/record.url?scp=85100645115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100645115&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2021.108671
DO - 10.1016/j.diabres.2021.108671
M3 - Article
C2 - 33493578
AN - SCOPUS:85100645115
SN - 0168-8227
VL - 173
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
M1 - 108671
ER -
